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Summary 
High endothelial venules (HEV) in lymphoid tlssues 
support high levels of lymphocyte extravasion from 
the blood. We purified high endothellal cells from hu- 
man tonsils by immunomagnetic selection with MECA- 
79 MAb to construct an HEV cDNA library. Differential 
screening of this library using cDNA probes from HEV 
(plus) or flat-walled vessel (minus) endothelial cells ai- 
lowed us to characterize a novel human cDNAexpressed 
to high levels in HEV. The cDNA encodes a secreted 
acidic calcium-binding glycoprotein of 664 aa resi- 
dues, designated hevin, exhiblting 62% identity with 
the antiadhesive extracellular matrix protein SPARC, 
over a region of 232 aa spanning more than four fifths 
of the SPARC coding sequence. The primary structure 
and sequence of hevin are similar to SPARClike pro- 
teins from rat and quail, called SC1 or Ml. Hevin could 
contribute to the induction or maintenance of features 
of the HEV endothelium that facilitate lymphocyte mi- 
gration. 
Introduction 
Patrolling the body in search of foreign antigen, lympho- 
cytes continuously recirculate from blood, through lym- 
phoid and other tissues, into the lymphatics, and back to 
the blood. This process, called lymphocyte recirculation, 
allows the dissemination of the immune response through- 
out the body and, thus, provides an effective immune sur- 
veillance for foreign invaders (Yednock and Rosen, 1989; 
Picker and Butcher, 1992). In human secondary lymphoid 
organs, such as lymph nodes, tonsils, adenoids, appendix, 
and Peyer’s patches, lymphocyte adherence and trans- 
endothelial migration occur at specialized postcapillary 
vascular sites called high endothelial venules (HEV). In 
contrast with the endothelial cells from other vessels, the 
high endothelial cells of HEV have a plump, almost cuboi- 
dal, appearance and are able to support high levels of 
lymphocyte extravasion (Marchesi and Gowans, 1963; An- 
derson et al., 1976). In chronic inflammation, the activated 
endothelium of nonlymphoid tissues has an HEV-like mor- 
phology and exerts functions in lymphocyte recruitment 
from the blood, comparable to high endothelium in lym- 
phoid tissues (Freemont, 1966). The plump morphology 
of endothelial cells from HEV, together with their striking 
plasticity, could represent a special adaptation to minimize 
the loss of blood fluid during lymphocyte transmigration 
(Schoefl, 1972). At the ultrastructural level, high endothe- 
lial cells are characterized by a prominent Golgi complex, 
abundant polyribosomes, and rough endoplasmic retic- 
ulum, revealing an intense biosynthetic activity not ob- 
served in “flar endothelial cells (Anderson et al., 1976; 
Freemont and Jones, 1963). Another typical feature of 
HEV, revealed by ultrastructural studies, is the existence 
of discontinuous “spot-welded” junctions between adja- 
cent high endothelial cells that resemble desmosomes 
(Anderson et al., 1976; Freemont and Jones, 1963). This 
latter characteristic is very important, since the absence 
of continuous “tight” junctions in HEV is likely to be one 
of the factors allowing massive lymphocyte migration (An- 
derson and Shaw, 1993). 
It was originally thought that a single receptor-counter- 
receptor pair would explain the specificity of lymphocyte 
migration through HEV. However, recent studies suggest 
that the molecular mechanisms conferring this specificity 
are more complex, with many different molecules involved 
in a multistep process (Springer, 1994). The initial interac- 
tion of lymphocytes with HEV in vivo under flow results 
in a loose transient adhesion, known as lymphocyte roiling 
(Bargatze and Butcher, 1993). In vitro studies have shown 
that lymphocyte L-selectin binds to the peripheral node ad- 
dressin, defined by MECA-79 monoclonal antibody (MAb) 
(Berg et al., 1991) and to its components, GlyCAM-1 
(La&y et al., 1992) and CD34 (Baumhueter et al., 1993) 
as well as to the mucosal addressin MAdCAM- (Berg et 
al., 1993) and that this interaction can mediate rolling 
(Berg et al., 1993) (Lawrence et al., submitted). Lympho- 
cytes rolling on HEV arrest in a process that is dependent 
on G protein-coupled receptors on lymphocytes(Bargatze 
and Butcher, 1993) and that likely involves chemoattrac- 
tant-stimulated activation of firm adhesion through inte- 
grins (Springer, 1994). Lymphocyte migration through 
HEV is very efficient, since it has been estimated that as 
many as 1.4 x 10’ lymphocytes extravasate from the 
blood into a single lymph node (via HEV) every second 
(Cahillet al., 1976).Theentireprocessof lymphocytestick- 
ing to HEV (rolling, activation, strong adhesion) takes only 
a few seconds (Bargatze and Butcher, 1993) while the 
transendothelial migration and the passage of lympho- 
cytes through the HEV basement membrane occur in 
about lo-15 min (Smith and Ford, 1963). 
HEV are likely to express many adhesion molecules and 
extracellular matrix proteins that facilitate the migration 
of lymphocytes between high endothelial cells and, thus, 
allow lymphocyte emigration in HEV to be so efficient. 
However, these molecules remain poorly characterized. 
Studies of the specialization of the HEV endothelium have 
been hampered by the fact that the lymphoid tissue envi- 
ronment is required to induce and maintain the HEV phe- 
notype (Hendriks and Eestermans, 1963; Mebius et al., 
1991b) and that high endothelial cells very rapidly lose 
their specialized phenotype when they are grown in vitro 
(Mebius et al., 1991 a). To characterize further the special- 
ization of the HEV endothelium at the molecular level, we 
designed a new strategy to isolate HEV-specific genes. 
We purified high endothelial cells from human tonsils by 
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Figure 1. Schematic of the Strategy Used to Purify High Endothelial 
Cells from Human Tonsils 
immunomagneticselection with the HEV-specific antibody 
MECA-79 (Streeter et al., 1988) and constructed a cDNA 
library with mRNA isolated from the purified high endothe- 
lial cells. Then, we screened this library by differential hy- 
bridization with HEV cDNAs as the positive probe and 
umbilical vein flat-walled endothelial cDNAs as the nega- 
tive probe. This strategy allowed us to characterize a novel 
human cDNA that encodes a 664 aa protein related to the 
antiadhesive extracellular matrix (ECM) secreted protein 
acidic and rich in cysteine (SPARC) (Lane and Sage, 
1994). Since the mRNA is abundant in HEV and absent 
from flat-walled endothelium, and encodes a protein ho- 
mologous to an ECM protein, we designate it hevin. We 
discuss potential roles of hevin in differentiation of the 
HEVendothelium and lymphocyte migration through HEV. 
Results 
Purification of High Endotheiiai Ceils 
from Human Tonsils 
We purified high endothelial venule cells from human ton- 
sils in four steps (Figure 1). Tonsils were minced finely 
with scissors on a steel screen under frequent flushing 
with media to remove most lymphocytes. To remove lym- 
phocytes trapped between or adherent to stromal ele- 
ments, stromal elements remaining on the screen were 
collected, incubated with collagenase under mild condi- 
tions, and the released lymphocytes were removed with 
a secondary screening step. The stromal elements were 
then subjected to strong collagenase digestion to obtain 
a single cell suspension, and stromal cells that passed 
through the screen were collected. indirect immunofluo- 
rescence staining with the HEV-specific MAb MECA-79 
showed that this tonsillar stromal cell suspension con- 
tained 1% of high endothelial cells (Figure 2a). We esti- 
mated that high endothelial cells accounted for 0.025% 
or less of the total cells from human tonsils, and that a 
40-fold enrichment in high endothelial cells was obtained 
(Table 1). lmmunomagnetic selection was used to sepa- 
rate further HEV endothelial cells from other tonsillar stro- 
mal cells. To select high endothelial cells, we used the 
MAb MECA-79 (provided by Dr. E. Butcher), which recog- 
nizes HEV ligands for lymphocyte L-selectin (Berg et al., 
1991) and inhibits lymphocyte homing to lymph node in 
vivo (Streeter et al., 1988). MECA-79 was a suitable re- 
agent for high endothelial cell purification, since it reacted 
strongly with all HEV present in human tonsils and did 
not cross-react with other cells (Michie et al., 1993). We 
labeled the tonsillar stromal cell suspension with MAb 
MECA-79 and paramagnetic beads, selected the mag- 
netic high endothelial cells with the Magnetic Cell Sorting 
system, and monitored the separation by flow cytometry 
(Figure 2a). In a typical experiment, about 3.7 x lo6 high 
endothelial cells were obtained in one preparation from 
four tonsils (Table 1). Under fluorescence microscopy, the 
purified high endothelial cells appeared as isolated single 
cells or small clusters of 2-l 0 cells (Figure 2~). They were 
heterogeneous in size, ranging from 15-20 pm in diameter 
(Figure 2d). Some of them retained a “cuboidal” morphol- 
ogy (Figure 2e). The enrichment in high endothelial cells 
obtained after the entire procedure was at least 2400-fold 
(Table 1). The typical purity of the HEV ceils was 600/o- 
65%, with a range of 500/b-90%, which was sufficient for 
most purposes. We repeated the purification procedure 
seven times to obtain enough magnetic cells (4.1 x 10’) 
for mRNA isolation, cDNA library construction, and cDNA 
probe synthesis. 
isoistion of an HEWSpecific cDNA (Hevin) 
by Differential Hybridization 
mRNA from the purified HEV endothelial cells was used 
to construct a cDNA library in the IZAPII vector. To isolate 
HEV-specific cDNAs, we screened duplicate filters from 
the cDNA library by differential hybridization. HEV cDNA 
was used as the plus probe. Human umbilical vein endo- 
thelial cells (HUVEC) were used as a source of flat endo- 
thelial cells. Since most of the ceils contaminating the high 
endothelial cell preparation appeared to be leukocytes 
(ICAMB’), the minus probe was prepared from a mixture 
of 20% mRNA from tonsil leukocytes and 80% HUVEC 
mRNA. Duplicate filter lifts from the HEV cDNA phage 
library (t5,OOO plaques plated at low density) were screened 
with the plus and minus probes to isolate clones specifi- 
cally detected with the HEV cDNA probe (Figure 3a). Se- 
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Figure 2. Purification of Human High Endothelial Cells by Immuno- 
magnetic Selection with the HEV-Specific MAb MECA-79 
(a) lmmunofluorescent flow cytometry of tonsillar stromal cells (after 
step 3 in Figure 1) and magnetic cells (after step 4 in Figure 1) stained 
with MECA-79 MAb. Cells were stained with MECA-79 for 15 min at 
4W and binding was detected with FITC-conjugated anti-rat K light 
chain MAb. 
(b) lmmunofluorescence staining of human tonsil frozen sections with 
HEV-specific MAb MECA-79. Frozen sections of human tonsils (8 wm, 
fixed with acetone) were stained with MECA-79 MAb for 1 hr in a 
quencing revealed that asignificant fraction of the differen- 
tially hybridizing clones encoded immunoglobulin chains, 
suggesting that plasma cells were a significant contamina- 
tion in the magnetic fraction. Since contaminating cells in 
the MECA-79+ magnetic fraction were likely also to be 
present in the MECA-79- nonmagnetic fraction of tonsillar 
stromal cells, a secondary screen was carried out. A plus 
cDNA probe was prepared from a highly purified magnetic 
tonsillar stromal cell fraction that contained 90% MECA- 
79+ cells and a minus cDNA probe was prepared from the 
MECA-79- (HEVdepleted) tonsillar stromal cells. Of five 
cDNA clones that differentially hybridized with the HEV 
probe versus HUVEC probe and represented novel human 
sequences, one also diff erentially hybridized in the second 
screen with the MECA-79+ and not the MECA-79- tonsillar 
stromal cell cDNA probes, whereas the four other cDNA 
clones were not sufficiently abundant to be detected by the 
limited amount of HEV (90% purity) cDNA probe available. 
We report here on the clone that is by far the most strongly 
expressed in HEV mRNA and is designated hevin. 
mRNA abundance in the MECA-79’ and MECA-79- ton- 
sillar stromal cell fractions was compared by hybridization 
of the respective cDNA probes with Southern blots pre- 
pared with cDNA encoding hevin, CD34, and IgA (Figures 
3b-3d). The MECA-79+ (HEV) cDNA probe intensely hy- 
bridized with the hevin cDNA (Figure 3d, lane 3), whereas 
the MECA-79- (HEVdepleted tonsillar stromal cell) cDNA 
probe was negative with hevin cDNA (Figure 3c, lane 3). 
The probes were also hybridized with a CD34 cDNA, be- 
cause CD34 is a major sulfo- and sialoglycoprotein of HEV 
that bears carbohydrate ligands for L-selectin (Baumhueter 
et al., 1993), and because CD34 is highly expressed on 
HEV in human tonsils (Girard and Springer, 1994). The 
MECA-79+ but not the MECA-79- tonsillar stromal cell 
cDNA probe hybridized with CD34 (Figures 3c and 3d, 
lanes 2). Interestingly, the intensity of hybridization of the 
MECA-79+ (HEV-enriched) cDNA probe was at least 20- 
fold greater with hevin cDNA than CD34 cDNA, suggesting 
that hevin is abundantly expressed in human HEV (Figure 
3d, compare lanes 2 and 3). By contrast with the above 
results, the MECA-79- (HEVdepleted) but not the MECA- 
79’ (HEV-enriched) cDNA probe strongly hybridized with 
IgA cDNA, suggesting that the MECA-79- tonsillar stromal 
cell preparation contained immunoglobulin A (IgA)-secret- 
ing plasma cells. 
In Situ Hybridization Analysis of Hevin mRNA 
Distribution in Human Tonsils 
To confirm the HEV-specific expression of hevin mRNA 
within human tonsils, a digoxigenin-labeled cDNA probe 
was hybridized in situ with cryostat tissue sections from 
moist chamber at room temperature and binding was detected with 
FITC-labeled secondary antibodies. Scale bar, 30 urn. 
(c-e) Fluorescence microscopy of same preparation as shown in (a), 
stained with MECA-79 and FITC-labeled secondary antibodies. The 
purified high endothelial cel!s are shown at low (c: scale bar, 30 pm), 
intermediate (d: scale bar, 10 pm), or high magnification (e: scale bar, 
5 vm). 
Table 1. HEV Cell Purification 
Fraction 
Tonsil suspension 
Stromal cell suspension 
Magnetic cell fraction 
Total cells HEV cells 
4 x IO’ 3.8 x IO8 
6 x lad 3.7 x 108 
HEV cells 
(percent) 
<0.025 
1 
60 
Enrichment 
1 
40 
2400 
human tonsils. The hevin probe selectively hybridized with 
HEV (Figure 4a). The dense cellular reaction product was 
confined to the cytoplasmic region of high endothelial cells 
(Figures 4b and 4c). No hybridization signal was detected 
with thin-walled vessels within tonsil (Figure 4d), or with 
any other cells within lymphoid or epithelial areas in tonsil 
(Figures 4a and 48). An IgA probe was used as a control. 
It hybridized intenselytiith single scattered cells that were 
numerous near the crypt epithelium areas of the tonsil and 
are likely to be IgA-secreting plasma cells (Figure 49. The 
IgA signal was detected after chromogen development for 
15 min, whereas the hevin signal was detected after 4 hr. 
Typically, 40% or more of the total protein synthesis in 
myelomacells isdevoted to the production of immunoglob- 
ulin chains (Harlow and Lane, 1988) and an estimate that 
heavy and light chain mRNA comprises 1%-5% of total 
cellular mRNA is unlikely to be far off (Dr. C. Milstein, 
personal communication). No nonspecific hybridization of 
the IgA probe with HEV was detected, and even after pro- 
longed exposure with the hevin cDNA probe, no cell8 other 
than HEVwere stained, showingthat within human tonsils, 
hevin is specifically eXpre8Sed in HEV. 
Nucleotide Sequence Analysis of Hevin cDNA 
Three essentially full-length hevin cDNA clones were iso- 
lated. The longest cDNA, which we sequenced on both 
strands, predicts an mRNA of 2645 bases (Figure 5a). The 
hevin cDNA consists of 198 nt of 5’ noncoding sequence, 
a single long open reading frame of 1992 nt encoding a 
putative protein of 664 aa with a calculated molecular 
mass of 75.2 kDa, and 455 nt of 3’ noncoding sequence. 
A good translational start site context (Kozak, 1984) sur- 
rounds the putative ATG initiation codon, and a consensus 
polyadenylation sequence AATAAA is found 16 nt up- 
stream of the poly(A) tail. 
The deduced amino acid sequence reveals that the 
hevin protein is composed of four regions (Figure 5b). The 
extreme N-terminal portion is predicted to be a signal pep- 
tide. It contains a hydrophobic stretch of 21 aa residues 
ending with a consensus signal peptidase cleavage site 
(von Heijne, 1986). From the beginning of the mature poly- 
peptide to residue 432, the sequence of hevin is highly 
acidic. This acidic domain contains 26% glutamic acid and 
aspartic acid residues. There are short tracts of glutamic 
acid (EEEEE, residues 201-205) and aspartic acid (DDD- 
GDDDGDD, residues 338-347). A third region of hevin, 
comprised of residues 433-516, is characterized by the 
presence of 11 cysteine residues (cysteine-rich domain). 
A fourth C-terminal region contains a 12 aa segment that 
is homologous to the calcium-binding loops of the EF-hand 
structures found in the calmodulin family of proteins (Kret- 
singer, 1980). The presence of a putative signal peptide 
and the lack of an internal hydrophobic membrane- 
spanning domain (Kyte-Doolittle predictions; Figure 5c) 
suggest that the hevin protein is secreted. The protein 
sequence contains seven Asn-X-Ser/Thr potential N-linked 
glycosylation sites (Figure 5a), consistent with the hypoth- 
esis that hevin may be glycosylated. 
Comparison of Hevln with the Extracellular Matrix 
Protein SPARC and Other SPARCLike Proteins 
The hevin sequence was compared with all sequences 
present in the National Center for Biotechnology Informa- 
tion nonredundant protein database using the BlASTP 
program (Altschul et al., 1990). This search revealed strik- 
ing similarities between hevin and the antiadhesive ECM 
protein SPARC (Figure 6). SPARC is a secreted calcium- 
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Figure 3. Isolation of an HEWSpecific cDNA by Differential Hybridiza- 
tion Screening 
(a) Primary screening. Duplicate filters from the HEV cDNA library 
were hybridized with HEV and HUVEC cDNA probes. The arrow indi- 
cates the position of a clone containing a cDNA (hevin) specifically 
detected with the HEV cDNA probe. 
(b-d) Secondary screening. cDNAs encoding IgA (lane l), CD34 (lane 
2) and hevin (lane 3) were released from plasmid DNA by digestion 
with EcoRl and Xhol, separated on a 1% agarose gel, stained with 
EtSr (b), and transferred onto nitrocellulose filters. Duplicate filters 
were then hybridized with a MECA-79. tonsillar stromal cell cDNA 
probe (MECA-79-), which is depleted of HEV cDNAs but contains many 
cDNAs from IgA-secreting cells (c), and a MECA-79 cDNA probe 
(MECA-79+), which is enriched in cDNAs from HEV endothelial cells 
(d). The positions of the IgA, CD34, and hevin cDNAs are indicated 
by arrows. 
;,+n, a New SPARC-Like Protein from Human HEV 
binding glycoprotein, widely expressed during develop- 
ment and tissue remodeling, that inhibits cell spreading 
and induces cell rounding by disrupting focal adhesions 
(Sage et al., 1989b; Murphy-Ullrich et al., 1991). The re- 
gion of sequence similarity corresponds to the C-terminal 
part of hevin and most of the SPARC coding sequence 
(Figure 8a). The database search also revealed that hevin 
is closely related to two other SPARC-like proteins: SC1 , 
a rat glycoprotein of 118/l 20 kDa expressed to high levels 
by many neurons in the brain (Johnston et al., 1990) and 
Figure 4. In Situ Hybridization to Hevin mRNA 
in Human Tonsil 
Cryostat sections (8 pm) of human tonsils were 
hybridized with digoxigenin-labeled cDNA 
probes. (a-e) Hevin mRNA detection (4 hr of 
chromogen reaction). 
(a) Hybridization signals are present in all HEV. 
Positive HEV are found in the interfollicular ar- 
eas (IF) while follicles are negative (F). Scale 
bar 120 urn. 
(b) A longitudinally sectioned HEV. 
(c)A cross-sectioned HEV. Signals are located 
predominantly in the cytoplasm of the plump 
high endothelial cells (arrow). L, lumen of the 
HEV. Scale bar, 30 pm. 
(d) Lack of expression of hevin mRNA in flat- 
walled vessels of the tonsils. L, lumen of nega- 
tive thin-walled vessels. Scale bar, 80 pm. 
(e) No detectable signals are seen in the crypt 
epithelium area of the tonsils. Scale bar, 
120 Km. 
(f) IgA mRNA detection (15 min of chromogen 
reaction). Strong hybridization signals are ob- 
served in IgA-producing cells infiltrating the 
crypt epithelium area of the tonsils. Scale bar, 
120 urn. 
QRl , an embryonic quail protein expressed byglial cell8 in 
the neuroretina(Guermah et al., 1991). The 232 C-terminal 
amino acids of hevin (from amino acid 433 to the C-terminal 
end) show respectively, 91%, 73%, and 82% identity to 
the homologous portions of rat SCl, quail QRl , and hu- 
man SPARC (Figure 6b). The N-terminal part of the four 
proteins is the most divergent, although a significant ho- 
mology is observed between the 432 N-terminal amino 
acids of hevin and the 402 N-terminal residues of rat SC1 
(53% identity). SPARC has a short N-terminal extension 
Figure5 Sequence of the cDNA Encoding 
Hevin 
(a) Nucleotide and deduced amino acid se- 
quence of the 2848 bp hevin cDNA. The num- 
bers on the right indicate amino acid positions 
in the unique long open reading frame. The 
putative signal sequence cleavage site is 
marked with an arrow. The polyadenylation sig- 
nal AATAAA is located 18 bp upstream of the 
poly(A) tail. Putative N-linked glycosylation 
sites are underlined. 
(b) Schematic representation of the hevin pro- 
tein. Horizontal hatched lines, putative signal 
peptide; shaded box, acidic domain; diagonal 
hatched lines, cysteine-rich domain; closed 
box, EF-hand calcium-binding domain. 
(c) Hydropathic profile determined by the Kyte 
and Doolittle algorithm (Kyte and Doolittle, 
1982). Hydrophobic regions are assigned posi- 
tive values. These sequence data are available 
from EMBUGenBanklDDBJ under accession 
number X82157. 
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Figure 6. Comparison of Hevin Deduced Amino Acid Sequence with 
SPARC and SPARC-Like Proteins, SC1 and OR1 
(a) Schematic representation of hevin, SPARC (Villarreal et al., 1989), 
SC1 (Johnson et al., 1990), and QRI (Guermah et al., 1991) proteins. 
The number of amino acid residues and the predicted isoelectric points 
of each protein are indicated. The percentage of amino acid sequence 
identity between domains of hevin and corresponding domains of 
SPARC, SCI, and QRl is shown. Horizontal hatched lines, signal 
peptides; shaded boxes, acidic domains; diagonal hatched lines, cys- 
teine-rich domains; closed boxes, EF-hand calcium-binding domains. 
(b)Amino acid sequence alignment of the C-terminal portions of human 
hevin, rat SCl, quail QRl, and human SPARC. Dashed lines indicate 
amino acid identities with hevin. Dots represent gaps introduced to 
align sequences. 
that is similar to the long N-terminal domain of hevin, SC1 , 
and QRl, in the sense that all contain clusters of acidic 
residues that impart an overall acidic pl to the proteins. 
Interestingly, the 14 cysteine residues found in SPARC 
are all present at homologous positions in hevin, SCl, 
and QRl . These include the 11 cysteine residues of the 
cysteine-rich domains that are similar to follistatin-like 
modules involved in cytokine binding (Lane and Sage, 
1994). Finally, the EF-hand calcium binding motif at the 
C terminus is present in all four proteins, suggesting an 
important role for calcium in the function of these proteins. 
Evolutionary Conservation of Hevin 
To characterize further the relationship of hevin with the 
two other SPAR&like proteins, rat SC1 and quail QRl, we 
performed cross-species Southern blots under moderate 
stringency hybridization conditions. The full-length hevin 
cDNA probe detects four fragments in human and monkey 
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Figure 7. Cross-Species Hybridization of Heyin cDNA with Genomic 
DNAs 
A Southern blot containing 4 Ng EcoFll-digested genomic DNA from 
nine different eukaryotic species (zoo blot, Clontech) was hybridized 
with a T-labeled full-length hevin cDNA probe. After a moderately 
stringent wash (2 x SSC, 0.1% SDS at 65OC), the blot was exposed 
to X-ray film at -80°C for 48 hr with intensifying screens. 
genomic DNA digested with EcoRl (Figure 7), one or two 
EcoRl fragments in rat, mouse, dog, and cow genomic 
DNA, and no fragment in rabbit, chicken, or yeast DNA. 
The 8 kb EcoRl fragment detected in the dog genome by 
the hevin cDNA probe is also detected by a rat SC1 cDNA 
probe (data not shown); close comparison of rat and hu- 
man hybridizing fragments was hindered because only a 
short rat SC1 cDNA probe was available that encodes 
amino acids 341-441, which contains little of the highly 
conserved region. The results suggest that hevin has been 
conserved in evolution and might be the human homolog 
of rat SCl. 
Distribution of Hevln mRNA Transcripts 
in Human Tissues 
Since SC1 is expressed in rat brain and heart (Johnston 
et al., 1990), we investigated further the expression of 
hevin in the human body. Hevin mRNA expression in 17 
different human tissues was examined by Northern blot 
(Figure 8a). A single mRNA species of 2.7 kb, correspond- 
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Figure 8. Northern Blot of Hevin cDNA with mRNA from Different Hu- 
man Tissues 
Each lane contains approximately 2 pg of poly(A)+ RNA isolated from 
the indicated human tissues. 
(a) The blot was hybridized, under high stringency conditions, with a 
“P-labeled probe encompassing the 5’ end of the HEVIN cDNA (1 .l 
kb Sac1 fragment). 
(b) After the removal of bound probe, the blot was reprobed with a 
“P-labeled human SPARC cDNA fragment. 
ing to the size of the hevin cDNA (2645 bp), is detected 
at high levels in lymph node, brain, heart, lung, skeletal 
muscle, ovary, small intestine, and colon. This 2.7 kb 
mRNA is also present at lower levels in placenta, pan- 
creas, testis, spleen, and thymus, but is absent in kidney, 
liver, and peripheral blood leukocytes. Furthermore, hevin 
mRNA was absent in HUVEC. Since high levels of hevin 
mRNA are expressed in many tissues that do not contain 
HEV, we conclude that expression of hevin is restricted 
to HEV in tonsils, but can occur on other cell types in other 
tissues. 
To investigate further the relationship between hevin 
and SPARC, the Northern blots were reprobed with a hu- 
man SPARC cDNA probe (Villarreal et al., 1969). Hevin 
and SPARC showed no cross-hybridization under the high 
stringency hybridization conditions used. Two mRNA spe- 
cies of 2.4 and 3.8 kb, distinct from the 2.7 kb hevin mes- 
sage, are detected with the SPARC probe (Figure 6b). 
Interestingly, the tissue distribution of SPARC message 
is clearly different from that of hevin. For example, SPARC 
is expressed to high levels in placenta and testis, and 
lower levels in brain, while hevin has an opposite expres- 
sion pattern in these tissues. Moreover, while hevin mRNA 
is not present in HUVEC, SPARC mRNA is clearly de- 
tected in these cells. 
A Novel Strategy to Characterize the Speclallzatlon 
of HEV at the Molecular Level 
HEV represent one of the most striking examples of endo- 
thelial differentiation. However, despite intensive efforts, 
the MECA-79 carbohydrate determinant is the only marker 
thus far described that is specific for HEV endothelium, 
and no gene specifically expressed in high endothelial 
cells has been described. CD34 is expressed on many 
typesof endothelial cells (Finaet al., 1990), and GlyCAM-1 
is abundantly expressed in epithelial cells of the lactating 
mammary gland as well as on HEV (Dowbenko et al., 
1993). Characterization of HEV is difficult, because they 
are a very minor component of lymphoid tissues, and thus 
far have only been partially purified by enrichment for ad- 
herent cells from lymph nodes (Ager and Mistry, 1990) or 
density gradient centrifugation (Chin et al., 1992). Further- 
more, HEV rapidly lose their specialized phenotype when 
isolated from the lymphoid tissue environment, even when 
this only consists of surgically severing the afferent lym- 
phatics while leaving the vascular blood supply intact 
(Mebius et al., 1991 b, 1991a). In this study, we have puri- 
fied HEV cells almost to homogeneity. The cells were puri- 
fied about 2,400-fold using differential collagenase diges- 
tion and immunomagnetic isolation with the MECA-79 
MAb. The preparations were, on average, at least 60% 
MECA-79+ as shown by immunofluorescence flow cytome- 
try, and up to 90% purity was achieved in one preparation. 
About 4 x 1 O6 HEV cells could be obtained in one prepara- 
tion from four tonsils. No in vitro culture was used during 
preparation, ensuring no alteration in phenotype. This 
method for purifying HEV cells may find many further appli- 
cations, including studying the function of HEV cells, and 
characterizing the conditions required for maintenance of 
the differentiated phenotype and growth of HEV cells. 
From the purified HEV cells, we obtained sufficient 
mRNA to construct a cDNA library and synthesize cDNA 
probes for hybridization. We used anovel strategy of differ- 
ential hybridization to isolate cDNA for messages ex- 
pressed in plump endothelial cells of HEV but not in flat 
endothelial cells of the human umbilical vein. We have 
illustrated this strategy with one of five different cDNAs 
isolated, that was by far the best expressed and the only 
one with homology to genes in the current sequence data- 
bases. Further work is required to confirm whether the 
other four mRNAs are specifically expressed in HEV. The 
cDNA we studied here encodes a 664 aa protein, desig- 
nated hevin, that is structurally related to the antiadhesive 
ECM protein SPARC. 
Hevin, a Novel Human SPARCLike Protein 
Unlike many other ECM-associated proteins, SPARC does 
not have any adhesive properties and, for instance, is not 
able to support endothelial cell attachment in vitro (Sage 
and Bornstein, 1991). In contrast, its antiadhesive proper- 
ties are impressive (Lane and Sage, 1994): SPARC inhibits 
endothelial cell spreading, induces cell rounding in well- 
spread endothelial cells (Sage et al., 1989b), and nega- 
tively modulates cell-substrate adhesion by stimulating 
the disruption of focal adhesions (Murphy-Ullrich et al., 
1991). The high degree of homology between hevin and 
SPARC, which exhibit 82% amino acid sequence identity 
over more than four fifths of the SPARC coding sequence, 
predicts that hevin is likely to have similar antiadhesive 
properties. This possibility is further supported by the fact 
that the region of homology includes the C-terminal EF-hand 
calcium-binding domain, which allows specific interaction 
of SPARC with endothelial cells (Yost and Sage, 1993) 
and mediates many of the antiadhesive effects of SPARC 
(Lane and Sage, 1990). Scanning electron microscopy 
studies have revealed striking effects of SPARC on endothe 
lial cell morphology and intercellular gap formation (Gold- 
blum et al., 1994): endothelial cells exposed to SPARC 
remain attached to the substrate but become rounded and 
assume a plump morphology with marked separation from 
neighboring cells (discontinuous junctions). Interestingly, 
the plump morphology of the endothelial cells and the dis- 
continuous junctions between adjacent endothelial cells 
are two prominent features of the specialized endothelium 
of HEV (Anderson and Shaw, 1993). These latter results, 
together with the high expression of hevin mRNA in HEV 
and the strong homology between hevin and SPARC, lead 
us to propose that hevin could be one of the factors contrib 
uting to the plump morphology of high endothelial cells 
and the presence of discontinuous junctions between high 
endothelial cells. Further studies, including expression of 
hevin, characterization of hevin at the protein level, and 
functional studies, are required to test this proposal. 
Although SPARC is expressed transiently in a wide range 
of cell types and tissues during development, in adults its 
expression is limited to tissues that are actively remodeling 
their matrix, where cells are dividing or migrating (Lane 
and Sage, 1994). The highest levels of SPARC mRNA are 
found in decidual cells of the endometrium, the steroid- 
producing Leydigcellsofthe testis, andthegranulosacells 
of the ovaries (Holland et al., 1987). SPARC expression is 
clearly associated with epithelia exhibiting high rates of 
turnover (gut, skin, glandular tissue). In newborn thymus, 
SPARC is associated with epithelial processes that pro- 
vide support for T cell populations (Sage et al., 1989a). 
In the adult, SPARC is not expressed in endothelial cells 
(except in endothelial cells associated with angiogenesis 
in vivo); however, its synthesis is rapidly induced in en- 
dothelial cells grown in vitro, as exemplified here with 
HUVEC. In contrast, hevin mRNA is expressed constitu- 
tively in HEV endothelial cells in vivo but is not detected 
in HUVEC grown in vitro. 
The high homology between human hevin and human 
SPARC indicates that hevin is clearly a SPARC-like pro- 
tein. However, hevin is more closely related to two other 
nonhuman SPARClike proteins than it is to human SPARC. 
The primary structure of these two SPARC-like proteins, 
rat SC1 and quail QRl, is very similar to that of hevin: 
in addition to the 232 aa C-terminal part homologous to 
SPARC, all these proteins have a long N-terminal domain 
of approximately 400 aa that is highly acidic (Figure 8). 
The presence of a putative signal peptide consisting of a 
hydrophobic stretch of 17-21 aa residues and the lack of 
an internal hydrophobic transmembrane domain suggest, 
as has been shown for SPARC, that these three SPARC- 
like proteins are secreted. One question that remains to 
be solved is whether these three SPARC-like proteins, 
which have been described in different species, are spe- 
cies homologs or are different members of the family of 
SPARC-like proteins. Hevin and quail QRl are unlikely 
to be species homologs, since QRl has low sequence 
similarity with hevin in the long N-terminal part and its 
expression appears to be restricted to glial cells in the 
quail neuroretina. In contrast, hevin and rat SC1 show 
many homologies: their N-terminal parts exhibit 53% iden- 
tity, they are both expressed to high levels in the brain 
and the heart and not expressed or expressed to low levels 
in kidney and liver, and the hevin cDNA probe detects the 
same dog EcoRl genomic DNA fragment as the SC1 cDNA 
probe. All together, these data suggest that hevin could 
be a human homolog of rat SC1 and are consistent with 
hevin being not a true HEV-specific protein but rather a 
major component of the ECM expressed in many tissues 
of the human body, including brain and heart. Interest- 
ingly, SC1 has been shown to be expressed strongly in 
Bergman glial cells and their radial fibers in the developing 
rat cerebellum, at a time when granule cells are migrating 
along these radial fibers, suggesting SC1 may play a role 
in cell migration (Mendis et al., 1994). Moreover, unlike 
many other ECM molecules, SC1 is widely expressed in 
the adult brain and is present in many types of neurons 
(Johnston et al., 1990). 
Possible Functions of Hevin in Lymphocyte 
Migration through HEV 
The high expression of hevin mRNA in HEV, together with 
its strong homology with SPARC, suggest different ways 
by which hevin could facilitate lymphocyte migration 
through HEV. We estimated that high endothelial cells 
from human tonsils expressed at least lo-fold higher levels 
of hevin mRNA than CD34 mRNA, although CD34, one 
of the ligands for lymphocyte L-selectin (Baumhueter et 
al., 1993) is itself abundantly expressed in human tonsil 
and murine peripheral lymph node HEV (Girard and 
Springer, 1994; Baumhueter et al., 1993). The abundance 
of the hevin mRNA in HEV is further inferred from the 
cloning of the hevin cDNA by differential screening, a 
method that allows only the detection of abundant mRNAs 
comprising more than about 0.05% of the total mRNA 
(Sambrook et al., 1989), and ready detection of hevin 
mRNA in Northern blots of lymphoid tissue, despite ex- 
pression in a small subset of cells. If hevin has the same 
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antiadhesive effects on endothelial cells as SPARC, it 
could facilitate the migration of lymphocytes through HEV 
by promoting the formation of intercellular gaps and dis- 
continuous junctions between high endothelial cells. Alter- 
natively, hevin could act on lymphocytes and modulate 
lymphocyte adhesion-deadhesion during transendothelial 
migration. Independently of its potential role as an adhe- 
sion modulator, hevin could also be involved in the presen- 
tation of adhesion-inducing cytokines to the lymphocytes 
rolling on or migrating across HEV. It has been hypothe- 
sized that proadhesive cytokines that mediate arrest of 
the rolling lymphocytes have to be immobilized on the 
luminal surface of endothelial cells to avoid being washed 
away by the blood flow (Rot, 1992; Tanaka et al., 1993b). 
Proteoglycans that contain long hydrophilic, acidic gly- 
cosaminoglycan side chains have been proposed as im- 
portant contributors for the immobilization of the basic 
chemokine MIPl -p on the luminal surface of HEV (Tanaka 
et al., 1993a). However, other molecules could be involved 
in this process. We would like to propose hevin as another 
good candidate for cytokine binding and immobilization 
on the luminal surface of HEV. Hevin could bind basic 
chemokines via its long N-terminal acidic domain or via 
its cysteine-rich follistatin-like module, which binds cyto- 
kines in other proteins (Patthy and Nikolics, 1993), while 
being retained on the surface of high endothelial cells via 
its SPARC-like C-terminal EF-hand calcium-binding do- 
main, which mediates specific interaction of SPARC with 
endothelial cells (Yost and Sage, 1993). It will be important 
to test this speculation by expressing the hevin protein, 
and testing its affinity for chemokines and its effects on 
chemokine immobilization on the surface of endothelium. 
Similarly, confirmation of a role for hevin in the induction 
or the maintenance of the differentiated phenotype of HEV 
will require further studies. 
ExperImental Procedures 
Prepsmtlon of Stromal Cell Suspensions from Human Tonsil 
The tonsillar stromal cell suspensions are prepared following the proto- 
col presented in Figure 1. After removal of blood clots, fresh human 
tonsils (Children’s Hospital, Boston, Massachusetts) are minced finely 
with scissors on a stainless steel screen (200 mesh = 74 pm, Type 
316, Tylinter, Mentor, Ohio) under frequent flushing with RPM1 1640 
medium to eliminate recirculating lymphocytes that pass through the 
screen. Stromal elements remaining on the screen are collected and 
incubated 15 min at 37OC in RPM1 1640 containing 0.5% collagenase 
(collagenase I, 187 Ulmg; Worthington Biochemical Corporation, Free- 
hold, New Jersey) and 2 &ml DNAse I (Sigma Chemical Company, 
St Louis, Missouri). After this mild collagenase treatment, the stromal 
elements suspension is placed on the steel screen and subjected to 
flushing to remove lymphocytes that were adherent to or trapped be- 
tween stromal elements. The stromal elements that remain after this 
step are resuspended in RPM1 1640 containing 0.5% collagenase and 
2 wglml DNAse I and incubated 60 min at 37OC with shaking. At the end 
of this strong collagenase digestion, remaining stromal cell aggregates 
are eliminated by retention on the steel screen, and the cells that pass 
through the screen are collected. The stromal cell suspension from 
four tonsils contains approximately 4 x 1Oe total cells and 4 x IO8 
high endothelial ceils (see Table 1; Figure 2b). 
lmmunomagnetlc Selection of Hlgh Endothellal Cells 
To enrich for high endothelial cells, we used the method of Magnetic 
Cell Sorting (Miltenyi Biotech, Sunnyvale, California). In brief, tonsillar 
stromal cells are stained with the HEV-specific antibody MECA-79 
tissue culture (rat IgMK), (Streeter et al., 1988) for 15 min at 4OC 
(4 x 10 cells in 4 ml MECA-79 tissue culture supernatant), washed 
with phosphate-buffered saline (PBS), 1% bovine serum albumin 
(BSA), incubated for 15 min at 4OC with a mouse MAb anti-rat K light 
chain (mouse IgGl, AMAC, Westbrook, Maine) diluted to 10 kg/ml in 
PBS, 1% BSA, and washed again with PBS, 1% BSA. The cells (in 
a final volume of 4 ml) are then incubated for 15 min at 10°C with a rat 
anti-mouse IgGl MAb conjugated to superparamagnetic microbeads 
(Miltenyi Biotech, Sunnyvale, California) diluted one fifth in PBS, 1% 
BSA, washed and, in a fourth step, incubated with fluorescein isothic- 
cyanate (FITQlabeled goat anti-mouse IgGl antibodies (Southern 
Biotechnology Associates, Birmingham, Alabama). After a final wash 
in PBS, 1% BSA, the cells are resuspended in 20 ml PBS, 1% BSA 
and applied to the topofatypeA2separation column (Miltenyi Biotech, 
Sunnyvale, California) in the Magnetic Cell Sorting magnetic separator 
with flow rate regulated by a 21 gauge needle. The column is washed 
with 20 ml PBS, 1% BSA at a higher flow speed regulated with a 18 
gauge needle and magnetic cells are then eluted by removing the 
column from the magnetic field and washing with 10 ml PBS, 1% BSA. 
Immunofluorescemce Microscopy and Plow Cytometry 
For immunohistochemistry, S pm acetone-fixed frozen sections of hu- 
man tonsilswere stained with the MAb MECA-79 in culture supernatant 
diluted lo one half with PBS, 1% BSA. for 1 hr in a moist chamber at 
room temperature, washed with PBS (three times for 5 min), incubated 
with an FITC-labeled mouse MAb anti-rat K light chain (AMAC, West- 
brook, Maine), washed again with PBS (three times for 5 min), then 
coverslipped usingf1uoromount-G media(FisherScientific. Pittsburgh, 
Pennsylvania). Fluorescence microscopy of tissue sections or small 
aliquots of cell suspensions was with a Zeiss microscope (Carl Zeiss, 
Thornwood, New York). Photographs were taken using a Nikon mi- 
croflex UFX-IIA (Nikon, Garden City, New York) and Kodak T-Max 400 
film. For flow cytometry, with an EPICS V (Coulter, Hialeah, Florida) 
a small fraction (1 (rcells) of the FITC-labeled stromal cell and magnetic 
cell populations was resuspended in 100 ~1 of PBS, 1% paraformal- 
dehyde. 
cDNA Library Constructlon and Screening 
Magnetic cell fractions (total of 4.1 x 10’ cells) containing purified 
high endothelial cells were pooled from seven separate preparations 
from a total of 28 tonsils. Poly(A) RNA was isolated with the mRNA 
isolation kit (Stratagene, La Jolla, California). A unidirectional cDNA 
library was prepared from this RNA using the ZAPII vector and cDNA 
cloning reagents from Stratagene (La Jolla, California). The original 
library contained 6 x lo6 recombinants before amplification. Primary 
screening of this library was performed by differential hybridization 
using as the plus probe HEV cDNA prepared during cDNA library 
construction (60% MECA-79+ HEV cells) and, as the minus probe, a 
mixture of 80% HUVEC cDNA and 20% tonsillar leukocyte cDNA. 
Probes were “P-labeled by random priming (GIBCO BRL, Grand Is- 
land, New York). Duplicate filter lifts (Amersham, Arlington Heights, 
Illinois) from five plates, each containing 3000 plaques, were hybrid- 
ized at 42OC overnight in 50% formamide. 5 x DenhardYs solution, 
0.5% SDS, 5x SSC. 50 &ml tRNA, and 50 vg/ml herring sperm 
DNA. The membranes were then washed with 1 x SSC, 0.1% SDS 
at room temperature (two times for 15 min) and 0.1 x SSC, 0.1% SDS 
at 5!?‘C (two times for 15 min). Plaques from differentially hybridizing 
clones were picked and the corresponding pBluescript II SK(-) phage 
mids rescued by in vivo excision using Exassist helper phage (Strata- 
gene, La Jolla, California). For the secondary screening, inserts were 
released from the plasmid DNA by digestion with restriction enzymes 
EcoRl and Xhol, separated on a 1% agarose gel, stained with ethidium 
bromide, and transferred to nitrocellulose filters. Duplicate filters were 
then screened by differential hybridization with pP-labeled cDNA 
probes from MECA-79’ (purified HEV) and MECA-79. (HEV-depleted) 
tonsillar stromal cells, using the same hybridization conditions as for 
the primary screening. The MECA-79+ magnetic stromal cell fraction 
used for probe generation contained 3 x lb high endothelial cells 
(90% purity determined by fluorescence microscopy). mRNA was iso- 
lated from these cells, and first-strand cDNA synthesized with the 
superscript preamplification system (GIBCO BRL, Grand Island, New 
York) was “P-labeled by random priming (GIBCO BRL, Grand Island, 
New York). The MECA-79. (HEV-depleted) tonsillar stromal cell cDNA 
probe was prepared in parallel using the same reagents. 
DNA Sequencing 
A nested series of deletions in the hevin cDNA was generated in both 
directions with the Erase a Base system (Promega Corporation, Madi- 
son, Wisconsin). Subclones containing progressive unidirectional de- 
letions covering the complete hevin cDNA (2645 bp) were sequenced 
with an ABI 373A automated DNA sequencer. Analysis of DNA se- 
quences was carried out on a VAX computer using the Genetics Com- 
puting Group program of the Wisconsin Genetics Group (Devereux 
et al., 1964). The program BLASTP (Altschul et al., 1990) was used to 
compare the hevindeduced amino acid sequence with all sequences 
present in the National Center for Biotechnology Information nonre- 
dundant protein database. 
In Sltu Hybrldlzetion 
Fresh human tonsils were cut in small pieces, embedded in CCT me- 
dium, quick-frozen in isopentane on dry ice, and stored at -60°C. 
Cryostat sections (6 pm) were collected on slides, fixed in freshly pre- 
pared 4% paraformaldehyde in PBS at room temperature for 15 min, 
washed in 3 x PBS, then twice in 1 x PBS, dehydrated in 30%, 60%, 
60%, 95%, 100% ethanol (2 min each), air dried, and stored at -60°C 
with desiccant. Sections were then equilibrated to room temperature, 
placed in moist chambers, and prehybridized at 42OC for 3 hr in 50% 
formamide, 5x SSC. 10x Denhardt, 2% SDS, 100 uglml herring 
sperm DNA. After prehybridiration, buffer was drained off, and 50 ul 
of the same solution, containing 100 ng digoxigenin-labeled probe, 
was pipetted onto the slides. After hybridization for 12-16 hr at 42OC 
in moist chambers, slides were washed at room temperature in 2 x 
SSC, 0.05% SDS (two times for 20 min). To remove unspecifically 
bound probe, slides were incubated at 50°C in 0.1 x SSC. 0.1% SDS 
(two times for 30 min). The detection of the digoxigenin-labeled probe 
was performed according to the instructions of the manufacturer (nu- 
cleic acid detection system Genius 3, Boehringer-Mannheim Corpora- 
tion, Indianapolis, Indiana). 
The probes used for in situ hybridization, a 0.6 kb BamHl fragment 
containing the 5’ part of the hevin cDNA, and a 0.6 kb EcoRI-Xhol 
fragment corresponding to the 3’ end of IgA cDNA, were labeled with 
digoxigenin-dUTP (Boehringer-Mannheim Corporation, Indianapolis, 
Indiana) by random priming (GIBCO BRL, Grand Island, New York). 
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